Mango....Bought BLUE at $34.20 pretty darn large after doing as much DD as I could given what is public.
This is a potentially totally disruptive gene altering technology that could change the course of how major diseases are treated, and/or, even prevented. If the platform works on sickle cell it will perhaps be one of the
largest break throughs in medicine during the last 50 years IMHO.
That of course is a very big IF. If the treatment fails the stock will tank. If there are major material side effects, or toxicity, the stock will tank. That is why IMHO Blue is such a high risk/high reward proposition. Not for the faint of heart...that's for sure.... But worth the bet? Yes...IMHO...
If sickle cell results prove ultra positive CELG is a likely buyer of BLUE IMHO...That is, if they are smart, and you know the answer to that one...lol!
Trtlracer..... Don't let the idiots here pooh pooh the recent move in BLUE... Bios in general are not doing crapola even in this recent bull move in stocks. If BLUE can close above it's old high of $41.75 it's a technical break-out and it's anyones guess where we go from there. Volume has been pretty good of late as well.
BLUE IMHO is either a $200 plus stock, or a $10 stock. I've made a large bet on the former. GLTALs....
Hanna... I said "great" results need to be shown by mid 2015. And proof of concept does not per se translate into a potential approveable product. IMHO.....
Hanna....Do not want to belabor the point but electric was always the better technology for the automobile and in fact the "electric" was sold and marketed in the US in the early 1920's and was fantastic car. But the range and battery life was so low it fell by the wayside to the gas driven automobile, Now today it is fairly obvious that the electric car could well be the future.
The point on RGLS was NOT the stock, nor the stock price. It was that they showed "RESULTS" that caught the attention of the investment community to the extent the stock doubled in price. R E S U L T S... !!
They had the same technology four days ago and the stock was $7, and even lower.
Why is this Board having so much trouble dealing with, or acknowledging the situation here?
No terrific results and we're going nowhere. No terrific results and we will see not institutioinal investment in the company, and major dilution is likely to follow. I frankly own more shares than 95% of the people here and am hanging on in hopes that we will show great results in the scarring trials by mid 2015. If not, I'll sell
and acknowledge a large loss, and make it back somewhere else.
The better "technology" is not always the winner unfortunately. If it were we'd been driving electric or steam vehicles a long time ago versus gasoline. The better mouse trap is not always the best seller. It's the one that catches the most mice that sells. Theory versus reality is sometimes a long way apart.
We are at that stage with RXII. We need to show results. We need to establish outright proof of concept...not just concept on a drawing board. At six to nine months the scars need to be dramatically different to the
naked eye. At a year even more so. Otherwise, everything else will be pretty moot.
We're under two bucks for goodness sakes in a market that is up 240 pts today! No believers out there. No real interest. We need a name partner to catch investor and institutional interest. Until one steps up and makes a large financial commitment to RXII the only logical conclusiion is that they too are waiting to see
results, versus simply technology and "theory". A Nobel prize is great for the recipient, but does nothing for this company frankly...We can dismiss the move in the stock price of RGLS form 7 to $15 in two days as
coming from inferior technolgy, but the bottom line is that their shareholders are twice as rich today as they were three days ago, and isn't that the bottom line pretty much in stock investing??
RNA technology acquired from ANLY has lead to very promising Hep C treatment and perhaps even a cure.
Still, the trials were small (16 patients) and only Phase 1, but the results were outstanding and the stock doubled!! We can do it too but we need to prove the concept with fantastic long lasting results in our Phase II.
OMG... Are we down to these types of posts now from a penny stock promoter wantabe? Good grief...
Can't we hear from the folks who actually still own this name, if any are left? At least the Twitter stock
guru guy, who some think may have bailed, had/has some positive things to say and report about the company. Hey...forgive and forget. At least his posts were entertaining and positive....
Hanna.... Not even sure now it is an issue of trusting the science. The time table to FDA approval is at least 4 years away. If you don't believe me go talk with IR. So between now and then catalysts for upward stock movement are going to be six months to a year apart. Also, the needs to raise money to fund the trials should be obvious. At $6 a share that would of been not so ultra dilutive. At $2 or less, it will be very dilutive.
Look...I'm ultra long, and at prices more than double what it is trading at today. But there is a reason the stock keeps hitting new lows just about every other day. This is going to be a very long road. 95% of the people who are posting here and who are ultra bullish won't be around for the pay off, if there ever is one. In fact, most will be long gone before the end of 2014. I've seen this literally dozens and dozens of times on message boards during the last 20 years.
People here aren't your friends, nor your enemies. They're simply trying to make a buck.
Just like all of us are. Misery likes company, and dillusion, so that's when the ultra bullish posts
really start to appear and usualy are crying "shorts" on top of MM's trying to steal your shares.
If one feels better grouping themselves with like minds that's fine, but those here now, including myself, don't know crapola, otherwise we would have all sold when the stock was over $6.50!
Reality check time, not bashing........
Yes...Definitely a $5 company, in your friggin stupid #$%$ mind. Listen dip sheet...You think Cowen can simply dump a stock worth $5 at $15 for 30 million dollars less than a month ago because of "hype" posted from some idiot Twitter stock guru? Come on man.....
Dosage is key in RNAi technology. It's gene suppression technology for goodness sakes. Too much and the entire gene that generates a programed response could be surpressed. Too little, and you do not get the desired result. The idea is to get the optimal dosage for the results desired without surpressing the gene too much. Kind of like making a Margarita! Too much juice and there's no effect. Too little juice and you're totally wasted.
If they ever want to get the drug approved they better well have a SPA with the FDA for their pivotal
Phase 3 trial....lol!
No.... But sometimes they allow a combined Phase2b and a Phase3, but it's pretty rare. This could be
one of those situations however because the drug is cosmetic, and any material adverse effects could probably be observed fairly easily. One the other hand RNAi is a fairly new technology so the FDA may want to be real careful with any new applications coming out of the box. My bet is they require a Phase 3 but it won't likely be a huge group...Maybe 60-100 subjects...max.